Diseases and disorders Books

Book SynopsisFunctional Foods, Nutraceuticals and Degenerative Disease Prevention is a compilation of different segments of functional foods and nutraceuticals focusing on their mechanism of action in the human body leading to disease prevention. Numerous chapters deal with different functional foods in terms of their efficacy, highlighting the mechanism of action of their ingredients. The book focuses on the biochemistry and molecular biology of the disease prevention process rather than simply compiling the benefits of functional foods and nutraceuticals. Aimed primarily at an audience comprised of researchers, industry professionals, food scientists, medical professionals and graduate level students, Functional Foods, Nutraceuticals and Degenerative Disease Prevention offers a mechanism-based interpretation for the effect of nutraceuticals within the human body. Ultimately, the discussion of the biological effects of a variety of functional foods will provide a wholesome approTable of ContentsContributors xv Preface xvii About the Editors xix 1 Functional Foods, Nutraceuticals, and Disease Prevention: A Window to the Future of Health Promotion 3 Gopinadhan Paliyath and Kalidas Shetty 1.1 Chronic Degenerative Diseases in Modern Society: Implications on Life Quality, Productivity, Economic Burden 3 1.1.1 Diet and lifestyle changes: the missing foods 3 1.1.2 Social and economic burden of chronic degenerative diseases 4 1.2 Health Regulatory Properties of Foods: “Prevention Is Better Than Cure” 5 1.2.1 Fruit and vegetable consumption and disease prevention 6 References 8 2 Functional Foods and Nutraceuticals 11 Chung-Ja C. Jackson and Gopinadhan Paliyath 2.1 Introduction 11 2.2 Definition of Functional Foods and Nutraceuticals 12 2.2.1 Effects of functional foods and nutraceuticals on major chronic diseases 16 2.3 Sources and Biological Effects of Functional Foods and Nutraceuticals in Nature 19 2.3.1 Flaxseed (Linum usitatissimum) 20 2.3.2 Phytoestrogens 21 2.3.3 Tomatoes 21 2.3.4 Garlic (Allium sativum) 21 2.3.5 Cruciferous vegetables 22 2.3.6 Citrus fruits 22 2.3.7 Cranberry 23 2.3.8 Tea 23 2.3.9 Wine and grapes 24 2.3.10 Chocolate 24 2.3.11 Fish 25 2.3.12 Dairy products 25 2.3.13 Carbohydrates 26 2.3.14 Meat 26 2.3.15 Vitamins 26 2.3.16 Minerals 27 2.4 Functional Foods and Nutraceuticals: Health Claims and Benefits 27 2.4.1 Oats 27 2.4.2 Psyllium 27 2.4.3 Soybeans 28 2.4.4 Phytosterols 29 2.4.5 Fiber 29 2.4.6 D-Tagatose 29 2.5 Qualifi ed Health Claims 29 2.5.1 Selenium and cancer 29 2.5.2 Antioxidant vitamins and cancer 30 2.5.3 Nuts (e.g., walnuts) and heart disease 30 2.5.4 Omega-3 fatty acids and CHD 30 2.5.5 Phosphatidylserine/Phosphatidylcholine and cognitive dysfunction and dementia 30 2.5.6 Folic acid and neural tube birth defects 30 2.6 Functional Foods and Nutraceuticals: Safety Issues 30 2.6.1 Echinacea 31 2.6.2 Ephedra (also called “ma huang, herbal ecstasy, or mahuanggen”) 31 2.6.3 Feverfew 31 2.6.4 Garlic 31 2.6.5 Ginger 32 2.6.6 Gingko biloba 32 2.6.7 Ginseng 32 2.6.8 Kava kava products 32 2.6.9 St. John’s Wort 32 2.7 Regulation of Functional Foods and Nutraceuticals 33 2.8 Public Education and Dietary Guidance 35 2.9 Concluding Remarks 36 References 37 3 Nutritional Genomics: Fundamental Role of Diet in Chronic Disease Prevention and Control 45 Amy J. Tucker, Branden Deschambault, and Marica Bakovic 3.1 Introduction 45 3.2 Nutrigenetics 46 3.2.1 Gene polymorphisms 46 3.2.2 Single nucleotide polymorphisms (SNPs) 47 3.2.3 Nonsynonymous single nucleotide polymorphisms (nsSNPs) 47 3.2.4 Regulatory single nucleotide polymorphisms (rSNPs) 48 3.2.5 Splice site single nucleotide polymorphisms (ssSNPs) 48 3.2.6 Trans-Acting rSNPs 48 3.3 Complexities of chronic disease research in nutrigenetics 49 3.4 Chronic Disease and Rare SNPs 50 3.4.1 Copy number variants 50 3.5 CVD and Nutrigenetics 51 3.6 Nutrigenetics and Cancer 51 3.7 Summary of Nutrigenetic Research Potential 51 3.8 Nutriepigenetics 52 3.8.1 Role of the epigenome 52 3.8.2 Cause of epimutations 52 3.9 Epimutations in Chronic Disease 53 3.9.1 Epimutations and macronutrients/micronutrients 53 3.9.2 Epimutations and phytochemicals 54 3.10 Summary of Epigenetic Research Potential 54 3.11 Nutrigenomics 54 3.11.1 Genomic impact of diet 55 3.11.2 Carbohydrates and gene interactions 55 3.12.3 Cholesterol and gene interactions 56 3.11.4 FAs, lipids, and gene interactions 58 3.11.5 Lipids and APOE 59 3.11.6 Diet and APOE 60 3.11.7 Lipids and hepatic lipase (HL) 60 3.11.8 Diet and LIPC 61 3.11.9 Interaction between APOE and HL 61 3.12 Vitamin A and Gene Interactions 61 3.12.1 Dual roles of vitamin A 62 3.13 Vitamin E and Nutrigenomics 62 3.13.1 Vitamin E and atherosclerosis 62 3.13.2 Vitamin E and cholesterol biosynthesis 63 3.14 Vitamin D and Gene Interactions 63 3.14.1 Vitamin D and breast cancer 63 3.14.2 Vitamin D and FAs 64 3.15 Phytoestrogens and Gene Interactions 64 3.15.1 Phytoestrogens and breast cancer 64 3.15.2 Phytoestrogens and lipid, glucose metabolism 64 3.16 Phytosterols and Gene Interactions 65 3.16.1 Phytosterols and cholesterol metabolism 65 3.16.2 Phytosterols and cancer 65 3.17 Polyphenols and Gene Interactions 65 3.17.1 Polyphenols and CVD 65 3.17.2 Polyphenols and cancer 66 3.18 Nutrigenomics Summary: Advantages, Limitations, Future 66 3.19 Conclusions 67 References 67 4 Nutraceuticals and Antioxidant Function 75 Denise Young, Rong Tsao, and Yoshinori Mine 4.1 Introduction 75 4.2 Oxidative Stress and ROS 75 4.2.1 Endogenous sources of ROS 76 4.2.2 Exogenous sources of ROS 77 4.3 Antioxidants and Antioxidative Defense Systems 77 4.3.1 Endogenous antioxidants and antioxidative defenses 77 4.3.2 Dietary antioxidants 79 4.4 Phytochemicals 79 4.4.1 Polyphenols 80 4.4.2 Amides 85 4.4.3 Carotenoids 86 4.4.4 Mechanism of antioxidant action 87 4.5 Antioxidant Amino Acids, Peptides, and Proteins 90 4.6 Mechanism of Action of Antioxidant and Antioxidative Stress Amino Acids, Peptides, and Proteins 91 4.6.1 Amino acids 91 4.6.2 Peptides and proteins 91 4.7 Production of Antioxidant Peptides 95 4.8 Recent Advances in Analytical Techniques for Measuring Antioxidant Capacity and Oxidative Damage 96 4.8.1 Chemical antioxidant capacity assay 96 4.8.2 Cell-based antioxidant assays 99 4.9 Health Benefi ts of Nutraceutical Antioxidants 101 4.9.1 Evidence of antioxidant efficacy in disease states 101 4.9.2 Failure of antioxidants to demonstrate efficacy 102 4.10 Conclusion 102 References 103 5 Composition and Chemistry of Functional Foods and Nutraceuticals: Infl uence on Bioaccessibility and Bioavailability 113 Jissy K. Jacob and Gopinadhan Paliyath 5.1 Introduction 113 5.2 Polyphenols as Antioxidants 115 5.2.1 Free radicals and endogenous antioxidant defense mechanisms 115 5.2.2 Diet and exogenous antioxidants (flavonoids) 115 5.2.3 Antioxidant properties of flavonoids 117 5.3 Antioxidant Activity of Anthocyanins 118 5.4 Anthocyanin Biosynthesis and Localization 119 5.5 Bioaccessibility and Bioavailability of Polyphenols 121 5.6 Microstructural Characteristics of Grape Juice 122 5.7 Physicochemical Properties of the Dialyzed Juice Fraction 123 5.8 Ultrastructural Analysis of Juice Fractions 124 5.9 Composition of Juice Fractions 126 5.10 Antioxidant Activity of Juice Fractions 129 5.11 Metabolism and Bioavailability of Flavonoids 132 5.12 Dietary Polyphenols and Prevention of Diseases 135 5.12.1 Polyphenols and cardiovascular diseases 135 5.12.2 Polyphenols and cancer 136 5.13 Increasing Health Benefi cial Properties of Juices 137 References 139 6 Cruciferous Vegetable-Derived Isothiocyanates and Cancer Prevention 147 Ravi P. Sahu and Sanjay K. Srivastava 6.1 Introduction 147 6.2 Metabolism of Xenobiotics 149 6.3 ITCs and Inhibition of Cancer 150 6.3.1 Pancreatic cancer 150 6.3.2 Brain cancer 152 6.3.3 Prostate cancer 152 6.3.4 Lung cancer 154 6.3.5 Breast cancer 155 6.3.6 Colon cancer 156 6.3.7 Hepatic cancer 156 6.3.8 Bladder cancer 157 6.3.9 Multiple myeloma (MM) 158 6.3.10 Head and neck squamous cancer 159 6.3.11 Ovarian cancer 159 6.3.12 Skin cancer 160 Acknowledgments 161 References 161 7 The Disease-Preventive Potential of Some Popular and Underutilized Seeds 171 Rajeev Bhat 7.1 Introduction 171 7.2 Oil Seeds and Their Therapeutic Potential 172 7.2.1 Nigella seeds (Nigella sativa L.) 172 7.2.2 Sunfl ower seed (Helianthus annuus L.) 172 7.2.3 Groundnut seed (Arachis hypogea L.) 183 7.2.4 Sesame seeds (Sesamum indicum L.) 184 7.2.5 Oilseed rape (Brassica napus L.) 184 7.2.6 Saffl ower (Carthamus tinctorius L.) 184 7.2.7 Linseed (Linum usitatissimum L.) 185 7.3 Spice Seeds as Medicine 185 7.3.1 Coriander seeds (Coriandrum satium L.) 185 7.3.2 Caraway (Cumin carvi L.) 186 7.3.3 Pepper seeds (Piper nigrum L.) 186 7.3.4 Cumin seeds (Cuminum cyminum L.) 186 7.3.5 Fenugreek seeds (Trigonella foenum-graecum L.) 187 7.4 Legumes and Medicinal Use 187 7.4.1 Soybeans (Glycine max (L.) Merrill) 187 7.4.2 Mucuna pruriens L. 188 7.4.3 Tamarind seeds (Tamaridus indica L.) 188 7.5 Underutilized Seeds 189 7.5.1 Perilla (Perilla frutescens [Hassk.]) 189 7.5.2 Hunteria umbellata ([K. Schum] Hallier f.) 189 7.5.3 Microula sikkimensis (Hemsl.) 189 7.5.4 Chinese chive seeds (Allium tuberosum Rottl.) 190 7.5.5 Grape seeds (Vitis vinifera L.) 190 7.5.6 Pumpkin seeds (Cucurbita sp.) 191 7.5.7 Horse chestnut seeds (Aesculus hippocastanum L.) 192 7.6 Future Outlook 192 References 193 8 Effects of Carotenoids and Retinoids on Immune-Mediated Chronic Inflammation in Infl ammatory Bowel Disease 213 Hua Zhang, Ming Fan, and Gopinadhan Paliyath 8.1 Introduction 213 8.2 Carotenoids 213 8.3 IBDs 214 8.4 Phytochemicals and Downregulation of IBD 215 8.4.1 Antioxidative capacity of carotenoids to reduce oxidative stress generated from inflammation 215 8.4.2 Immune-modulating activity of carotenoids 216 8.5 Effects of Carotenoids on Immune Genetic Mechanism of IBD 221 8.5.1 Potential role of retinoid receptors in attenuation of inflammatory diseases 222 8.5.2 Modulation of inflammatory responses through activation of nuclear receptors containing RXR heterodimers 223 8.6 Effects of Retinoids and Carotenoids on the Oxidative Stress Signaling Pathway 226 References 229 9 Ruminant Trans Fat as Potential Nutraceutical Components to Prevent Cancer and Cardiovascular Disease 235 Ye Wang, Catherine J. Field, and Spencer D. Proctor 9.1 Introduction 235 9.2 c9,t11-CLA Isomer and Health Implications 237 9.2.1 CLA modulates carcinogenesis 237 9.3 Mechanisms of CLA Action on Cancer 245 9.4 CLA Modulates CHD Risk Factors 245 9.5 Mechanisms of CLA Action on CHD 246 9.6 Vaccenic Acid 252 9.6.1 VA modulates carcinogenesis 253 9.6.2 VA modulates CVD risk factors 253 9.7 Dairy Fat Enriched with VA and CLA 254 9.7.1 Enriched dairy fat modulates carcinogenesis 254 9.7.2 Enriched dairy fat modulates CVD risk factors 255 9.8 Discussion 255 References 256 10 Nanotechnology for Cerebral Delivery of Nutraceuticals for the Treatment of Neurodegenerative Diseases 263 Jasjeet Kaur Sahni, Sihem Doggui, Lé Dao, and Charles Ramassamy 10.1 Introduction 263 10.2 Oxidative Stress in Mild Cognitive Impairment (MCI) and AD 264 10.3 Efficacy of Selected Components of Nutraceutical Compounds in the Amyloid Cascade and in the Prevention of AD 266 10.4 Targeted NPs for Delivery of Bioactives Compounds from Foods for the Treatment of AD 272 10.4.1 Catechins coupled with NPs 272 10.4.2 NPs targeted with ApoE containing curcumin 273 10.4.3 Resveratrol-loaded NPs protect againt Aß-induced toxicity 275 10.5 Conclusion 275 References 275 11 Cancer Prevention by Polyphenols: Influence on Signal Transduction and Gene Expression 285 Fatima Hakimuddin and Gopinadhan Paliyath 11.1 Introduction 285 11.2 Genetic Mechanisms of Carcinogenesis 285 11.3 Biochemical Mechanisms of Carcinogenesis 287 11.3.1 Pathways and signals involved in neoplastic cell transformation and carcinogenesis 287 11.3.2 Extracellular signal transduction 288 11.3.3 Intracellular signal transduction 289 11.4 Signaling Pathways in Breast Cancer 291 11.4.1 Calcium homeostasis and signaling 292 11.4.2 Role of calcium in regulating cell proliferation and cell cycle 293 11.4.3 Regulation of the cell cycle by calmodulin 293 11.4.4 Calcium signaling and cell death 293 11.4.5 Mitochondria, calcium signaling, and apoptosis 294 11.5 Cancer Prevention and Therapy 294 11.5.1 Targeted therapies 294 11.5.2 Phytochemicals and cancer prevention 296 11.6 Grapes and Red Wine as a Dietary Source of Polyphenols 298 11.6.1 Health benefi ts of red wine 298 11.6.2 Modulation of signaling pathways by fl avonoids 306 11.7 Genetic Approach: Identifi cation of Flavonoid Mediated Molecular Targets 308 11.8 Estrogen Metabolism, Breast Cancer, and Flavonoids 311 11.9 Polyphenols and Estrogen Signaling 312 References 313 12 Potato–Herb Synergies as Food Designs for Hyperglycemia and Hypertension Management 325 Fahad Saleem, Ali Hussein Eid, and Kalidas Shetty 12.1 Introduction 325 12.2 Phenolic-Enriched Chilean Potato and Select Species of Apiaceae and Lamiaceae Families in Diet 327 12.3 Combination of Potato with Seeds and/or Herbs for Hypertension and Hyperglycemia Management 331 12.3.1 Chilean potato (Solanum tuberosum ssp. tubersocum L.) 331 12.3.2 Apiaceae family 333 12.3.3 Lamiaceae family 335 12.4 Conclusions: Combining the Chilean Potato with Seeds and Herbs from the Apiaceae and Lamiaceae Families 336 References 338 13 Fermentation-Based Processing of Food Botanicals for Mobilization of Phenolic Phytochemicals for Type 2 Diabetes Management 341 Chandrakant Ankolekar and Kalidas Shetty 13.1 Introduction 341 13.2 Diabetes: The Rising Burden 342 13.3 Fermentation and Health: A Historical Perspective 342 13.4 Fermentation: Adding Value 343 13.4.1 Preservation of food through acid/alcohol formation 343 13.4.2 Enrichment of food substrates through formation of micro and macro nutrients 344 13.4.3 Flavor, aroma, and texture development 344 13.4.4 Detoxification of substrates during fermentation 345 13.5 Phenolic Antioxidants and Diabetes Management 345 13.6 Microbial Aerobic Growth and Fermentation and Its Anti-Diabetes Potential by Phenolic and Antioxidant Mobilization 346 13.6.1 Solid State Growth (SSG) 346 13.6.2 Liquid state (submerged) fermentation 347 13.7 Fruit Juice Fermentation for Healthy Food Ingredients for Management of Type 2 Diabetes 348 13.7.1 Apple juice fermentation 348 13.7.2 Pear juice fermentation 349 13.7.3 Cherry juice fermentation 349 13.8 Summary 350 References 351 14 Postharvest Strategies to Enhance Bioactive Ingredients for Type 2 Diabetes Management and Heart Health 357 Dipayan Sarkar and Kalidas Shetty 14.1 Introduction 357 14.2 Changing Dietary Patterns: A Historical Perspective 357 14.3 Noncommunicable Chronic Diseases: Era of New Global Epidemics 358 14.4 Healthy Diet: “Prevention Is Better Than Cure” 360 14.4.1 Fruits and vegetables: from garden of eden to modern horticulture 360 14.5 Bioactive Ingredients 361 14.6 Dietary Polyphenols: Impact on Human Health 362 14.6.1 Role of polyphenols in glucose metabolism 362 14.6.2 Polyphenols and cardiovascular disease 364 14.7 Phenolic Biosynthesis: Biological Mechanism to Improve Dietary Polyphenols in Plant Models 365 14.8 Postharvest Strategies to Improve Bioactive Ingredients in Fruits and Vegetables 367 14.8.1 Temperature 367 14.8.2 Light and oxygen 368 14.8.3 Chemical treatment and natural compounds 368 14.9 Phenolic-Linked Antioxidant Activity During Postharvest Stages in Fruits and Relevance for Type 2 Diabetes 369 14.10 Future Direction of Research: When Functional Food and Diet Become “Panacea” 370 14.10.1 Stage 1: physiology and growth during germination to maturity 370 14.10.2 Stage 2: postharvest management 371 14.10.3 Stage 3: food processing 371 14.10.4 Stage 4: biotechnological tools 372 14.10.5 Stage 5: in vitro studies 372 14.10.6 Stage 6: animal, clinical, and epidemiological studies 372 14.10.7 Stage 7: marketing, awareness, and education 373 14.11 Conclusions 373 References 373 15 Enhancing Functional Food Ingredients in Fruits and Vegetables 381 Shaila Wadud and Gopinadhan Paliyath 15.1 Introduction 381 15.2 Strategies for Nutritional Enhancement 382 15.3 Improving the Mineral Content of Plant Foods 383 15.3.1 Iron and zinc 384 15.4 Improving the Antioxidants Content of Plant Foods 385 15.4.1 Lycopene and ß-carotene 385 15.4.2 Vitamin E 387 15.4.3 Flavonoids 387 15.5 Improving the Amino Acid Content of Proteins of Plant Foods 389 15.6 Improving the Fatty Acid Composition of Plant Seed Oil 390 15.7 Influence of Processing and Storage in the Nutritive Value of Plant Foods 391 15.7.1 Processing of plant oils 391 15.7.2 Processing of fruits and vegetables 391 References 392 Index 395

Read more less

Book SynopsisObesity is becoming increasingly prevalent in a worldwide context, and has been recognised as a major contributing factor in heart disease. This volume was authored by the participants in a 1998 AHA sponsored conference on the impact of obesity on cardiovascular disease. The three main sections of the book set out to evaluate current research pertaining to causation and cardiovascular sequela of obesity. Part I defines obesity, exploring its epidemiology, its genetic and non-genetic influences and its contribution to the problem of cardiovascular disease. Special attention is given to the primary prevention of obesity as a means of avoiding specific sequelae as well as the difficulties experienced by those who try to lose weight. Part II deals with the relatively new and much heralded discovery of obesity related genes the current state of diet drugs and valvular heart disease, and the interaction of obesity and metabolism, hormonal regulation and various other biological systems. RTrade Review"This is a superb and needed book."—American Journal of Cardiology "This book may best be considered an excellent update on obesity."—Texas Heart Institute Journal "Excellent Four Stars. A comprehensive review of an important clinical area in which treatment options are badly needed."—Mayo Clinic ProceedingsTable of ContentsContributors. Acknowledgement. Preface. (S.M. Grundy). Part 1: Epidemiology of Obesity. Chapter 1. Epidemiology of Obesity in Adults in Relationship to Cardiovascular Disease. (L.H. Kuller). Chapter 2. Obesity in Children, Adolescents and Families. (E. Obarzanek). Chapter 3. Developmental Aspects of Obesity: Genetic Influences. (T.L. Burns). Chapter 4. Developmental Aspects of Obesity: Nongenetic Influences. (L.L. Hayman). Chapter 5. Prevention of Obesity. (S.R. Daniels). Part 2: Pathophysiology of Disease. Chapter 6. Obesity Related Genes. (R.M. Krauss). Chapter 7. Diet Drugs and Valvular Heart DIsease. (G.P. Aurigemma). Chapter 8. Mechanisms of Obesity Hypertension and Relevance to Essential Hypertension. (J.E. Hall, M.W. Brands, D.W. Jones, E.W. Shek, J. Henegar). Chapter 9. Obesity and Lipoprotein Metabolism: Relationship to Cardiovascular Disease. (B.V. Howard). Chapter 10. Is Insulin Resistance and Independent Risk Factor for Coronary Heart Disease? (S.M. Grundy). Chapter 11. Obesity and Postmenopausal Women. (K.M. Newton). Chapter 12. Late Breaking Advances in the Biological Understanding of Obesity and its Sequelae. (R.H. Eckel). Part 3: Assessment, Interventions, Treatment and Outcomes. Chapter 13. Body Composition Assessment: Epidemiological, Clinical and Research Tools. (M.E. Sweeney). Chapter 14. Dietary Strategies: Issues of Diet Composition. (S.T. St. Jeor, J.M. Ashley). Chapter 15. Energy Expenditure and Obesity. (J.O. Hill, Adamandia D. Kriketos). Chapter 16. Physical Activity in the Management of Obesity: Issues and Implementation. (M.L. Stefanick). Chapter 17. Efficacy and Safety of Pharmacological Interventions for the Overweight Patient. (G.A. Bray). Chapter 18. Behavioural Interaction. (J.P. Foreyt, W.S. Carlos Poston). Chapter 19. Strategies to Enhance Compliance to Weight-Loss Treatment. (L.E. Burke). Chapter 20. Quality of Life and Obesity. (M.R. Kinney). Chapter 21. Economic Impact of Obesity and its Cardiovascular Sequelae in Managed Care Settings. (K. McManus). Summary. (G.F. Fletcher). Index.

Read more less

Book Synopsis

Read more less

Book Synopsis

Read more less

Book SynopsisImagine waking up feeling refreshed, strong, and vibrant, with your hormones in balance and your body nourished, stable, and supported on both the emotional and physical levels. For the millions who are grappling with rheumatoid arthritis, Hashimoto's thyroiditis, inflammatory bowel disease, type one diabetes, and numerous other autoimmune conditions, this vision seems so distant from the daily reality that it seems an impossibility. In spite of increasing knowledge and awareness, the causes and effects of autoimmune conditions are often misunderstood, and the connection between inner well-being and physical health is not fully explored.As an acupuncturist and herbalist with over 15 years of clinical experience, Aimee Raupp, M.S., L.Ac., has treated a variety of autoimmune conditions, as well as managed her own. Her Body Belief Plan bridges the gap between our internal and external healing to present a holistic and practical approach based on the core pillars of reconnecting to ourselvTrade Review"Aimee is a beacon of hope for all looking to improve their health and awaken their best life."— Deepak Chopra, M.D."Body Belief is must reading for every person who has ever felt sick and tired and doesn't know what's wrong. Rooted in compassion, rich with solid medical advice, and written by someone who has been there, Body Belief is a true treasure of life-changing information that will assist anyone in healing their body and their life."— Christiane Northrup, M.D., New York Times best-selling author of Women's Bodies, Women's Wisdom"Aimee Raupp is one of the most kind, generous, and talented healers. Her teachings have allowed me to transform the way I think about my body and my healing path. If you are longing to reawaken your health, Body Belief is the book you need and Aimee is the healer you want."— Gabrielle Bernstein, #1 New York Times best-selling author of The Universe Has Your Back"Aimee's teachings are filled with an immense amount of knowledge and research combined with real-life experience and a good dose of humor. In a masterful way, she equips her clients and followers with practical tools for achieving and maintaining optimal health and vitality despite the challenges of a modern lifestyle. She pours her wisdom and expertise and infuses her clients with the healing tools of self-love and self-acceptance."— Agapi Stassinopoulos, author of Wake Up to the Joy of You"Aimee Raupp understands that self-love can heal all parts of you—body and soul—and she can show you the path toward whole health in all its forms."— Rebekah Borucki, author of You Have 4 Minutes to Change Your Life"Aimee's message is a call to action for women of all ages to take control of their health through a path of self-love. The benefits transcend physical healing, aligning body, mind, and spirit to create optimal well-being and vitality."— Claudia Chan, author of This Is How We Rise

Read more less

Book SynopsisDesigned for the practitioner, this handbook provides an easy-to-read overview of how to evaluate and treat patients with a history of fainting. The 2nd Edition has been fully revised to contain all the latest information concerning diagnosis and treatment. It is based on the 2004 update of the ESC Guidelines on the Management of Syncope and offers up-to-date direction based on comprehensive analysis. All chapters share a consistent structure and are concise - only essential references are included. However, each chapter comes with suggestions for further reading and a comprehensive literature source is provided separately at the end of the book and divided into major interest areas. The ESC Education Series This book is part of the ESC Education Series. The series is designed to provide medical professionals with the latest information about the understanding, diagnosis and treatment of cardiovascular diseases. Where avTrade Review"This comprehensive tome is the most in depth presentation of the evaluation and treatment of patients with a history of fainting that I have come across.... You will learn a lot." (Cardiology News, June 2009)Table of ContentsSection one: Definition, pathophysiology, epidemiology. Chapter 1 Syncope: definition, classification, and multiple potential causes. Jean-Jacques Blanc, David G. Benditt. Chapter 2 Whatis syncope and whatis notsyncope: the importance of definitions. J. Gert van Dijk, Adam P. Fitzpatrick. Chapter 3 Pathophysiology and clinical presentation. Wouter Wieling, J. Gert van Dijk, Johannes J. van Lieshout, David G. Benditt. Chapter 4 Maintaining blood pressure while upright: physiology and potential for disturbances to cause syncope. Christopher J. Mathias. Chapter 5 Epidemiology and social costs of syncope. Rose Anne Kenny, Wishwa N. Kapoor. Section two: Syncope evaluation strategy. Chapter 6 Overview of recommended diagnostic strategies. Richard Sutton, Michele Brignole. Chapter 7 Initial evaluation of the syncope patient. Antonio Raviele, Paolo Alboni. Chapter 8 The role of the prepared questionnaire in initial evaluation of transient losses of consciousness. Anna Serletis, Robert S. Sheldon. Chapter 9 Who should be evaluated and treated in hospital, and who can be managed as an outpatient?. David G. Benditt. Chapter 10 Organizing management of syncope in the hospital and clinic (the syncope unit). Rose Anne Kenny, Michele Brignole. Chapter 11 Impact of syncope guidelines on clinical care. Michele Brignole. Section three: Specific diagnostic procedures. Chapter 12 Ambulatory electrocardiographic monitoring for evaluation of syncope. Adam P. Fitzpatrick, David G. Benditt. Chapter 13 Hemodynamic sensors: the future evaluation of syncope. David G. Benditt. Chapter 14 The basic autonomic assessment. Richard Sutton, David G. Benditt. Chapter 15 Electrophysiological testing. Fei Lü, Lennart Bergfeldt. Chapter 16 Miscellaneous diagnostic procedures: when are they indicated?. Lennart Bergfeldt, Piotr Kulakowski. Chapter 17 Neurologic diagnostic procedures in syncope. J. Gert van Dijk. Chapter 18 Contribution of psychiatric disorders to apparent syncope. George Theodorakis. Section four: Causes of syncope and syncope mimics, and treatment. Chapter 19 Who to treat. Michele Brignole, Rose Anne Kenny. Chapter 20 Specific causes of syncope: their evaluation and treatment strategies. Part 1 Neurally mediated reflex syncope. David G. Benditt, Jean-Jacques Blanc. Part 2 Orthostatic syncope. Angel Moya, Wouter Wieling. Part 3 Cardiac arrhythmias and conduction system disease as a primary cause of syncope. Angel Moya. Part 4 Structural cardiac and pulmonary causes of syncope. Jean-Jacques Blanc, Jan Janousek. Part 5 Cerebrovascular disorders as the primary cause of syncope. J. Gert van Dijk. Chapter 21 Syncope and other causes of transient loss of consciousness in children, teenagers, and adolescents. Wouter Wieling, Karin S. Ganzeboom, Jan Janousek. Chapter 22 Syncope in the older adult (including driving implications). Rose Anne Kenny, David G. Benditt. Chapter 23 Conditions that mimic syncope. J. Gert van Dijk. Section five: Selected references since 1990. Index

Read more less

Book SynopsisA recent upsurge of research examining inositol phospholipids (IP)—membrane-bound species fundamental to cell signaling—continues underscore the role of this pathway in both normal and disease-associated cellular physiology. This volume includes a selection of cutting-edge, multidisciplinary reports borne out of the conference “Inositol Phospholipid Signaling in Physiology and Disease” held June 26–27, 2012 at the New York Academy of Sciences in New York City. Papers include important developments investigating IP signaling in immunology, cancer, inflammation, and metabolic disorders. NOTE: Annals volumes are available for sale as individual books or as a journal. For information on institutional journal subscriptions, please visit: http://ordering.onlinelibrary.wiley.com/subs.asp?ref=1749-6632&doi=10.111/(ISSN)1749-6632. ACADEMY MEMBERS: Please contact the New York Academy of Sciences directly to place your order (www.nyas.org). Members of the New York Academy of Science receive full-text access to Annals online and discounts on print volumes. Please visit http://www.nyas.org/MemberCenter/Join.aspx for more information on becoming a member.Table of ContentsIntroduction to Inositol Phospholipid Signaling in Physiology and Disease v William G. Kerr and Sandra Fernandes Phosphoinositide 3-kinase and INPP4B in human breast cancer 1 Micka C. Bertucci and Christina A. Mitchell Role of SHIP1 in cancer and mucosal inflammation 6 Sandra Fernandes, Sonia Iyer, and William G. Kerr Role of SHIP1 in bone biology 11 Sonia Iyer, Bryan S. Margulies, and William G. Kerr Achieving cancer cell death with PI3K/mTOR-targeted therapies 15 Sung Su Yea and David A. Fruman Challenges in the clinical development of PI3K inhibitors 19 Cristian Massacesi, Emmanuelle di Tomaso, Nathalie Fretault, and Samit Hirawat Rules of engagement: distinct functions for the four class I PI3K catalytic isoforms in immunity 24 Klaus Okkenhaug Control of T cell tolerance by phosphatase and tensin homolog 27 Alexandria Huynh and Laurence A. Turka Role of PI3K/Akt and mTOR complexes in Th17 cell differentiation 30 Shigenori Nagai, Yutaka Kurebayashi, and Shigeo Koyasu Targeting phosphoinositide 3-kinase δ for the treatment of respiratory diseases 35 Srividya Sriskantharajah, Nicole Hamblin, Sally Worsley, Andrew R. Calver, Edith M. Hessel, and Augustin Amour Phosphoinositide 3-kinase gamma in T cell biology and disease therapy 40 Wai-Ping Fung-Leung Inhibition of phosphoinositide 3-kinase γ attenuates inflammation, obesity, and cardiovascular risk factors 44 Matthias P. Wymann and Giovanni Solinas Class III PI3K Vps34: essential roles in autophagy, endocytosis, and heart and liver function 48 Nadia Jaber and Wei-Xing Zong Inpp4b is a novel negative modulator of osteoclast differentiation and a prognostic locus for human osteoporosis 52 Jean Vacher

Read more less

Book Synopsis

Read more less

Book SynopsisHas a chronic health issue taken over your life? More than half of us in the US are struggling with at least one. Amy Kurtz gets it. Starting in her mid-teens, she endured two perfect storms of illness that progressed into her twenties. It earned her the label "the sick chick"—and the shame, fear, isolation, and frustration that comes with it. She’s radically improved her health, and today she’s helping men and women of all ages live well regardless of their health situation. With honesty, humor, and empathy, Kicking Sick shows you how to jettison despair, tune in to your body and inner wisdom, take charge, and build an effective support circle of medical experts, friends, and family. Kicking Sick also brings you essential advice from Amy’s own A-team of experts—the ones crucial to her own turnaround: her personal physician Mark Hyman, gastroenterologist Gerard Mullin, endocrinologist Philip Felig, Crazy Sexy Cancer author Kris Carr, new thought leader Gabby Bernstein, and renowned yogi Elena Brower, plus many real life "glow warriors."

Read more less

Book Synopsis

Read more less

Book Synopsis

Read more less

Book Synopsis

Read more less

Book Synopsis

Read more less

Book Synopsis

Read more less

Book Synopsis

Read more less

Book Synopsis

Read more less

Book Synopsis

Read more less

Book Synopsis

Read more less

Book Synopsis

Read more less

Book Synopsis

Read more less

Book Synopsis

Read more less

Book Synopsis

Read more less

Book Synopsis

Read more less

Book Synopsis

Read more less

Book Synopsis

Read more less

Book Synopsis

Read more less

Book Synopsis

Read more less

Book Synopsis

Read more less

Book Synopsis

Read more less

Book Synopsis

Read more less